FDA Approves Emergency Use of Anti-Malarial Drugs to Treat People Infected with COVID-19
(Worthy News) – The US government is giving reserved approval to two new weapons in the war against the COVID-19 virus, which has so far claimed the lives of more than 2,500 in the US and a total of 35,300 people around the world.
The Food and Drug Administration (FDA) cut the red tape to give limited emergency-use approval to use the oral anti-malarial drugs chloroquine and hydroxychloroquine to treat patients infected with the novel coronavirus.
In a statement released Sunday night, the US Department of Health and Human Services announced it had received 30 million doses of hydroxychloroquine and one million doses of chloroquine donated to a national stockpile of potentially life-saving pharmaceuticals and medical supplies from the Swiss pharmaceutical giant Novartis. [ Source: CBN News (Read More…) ]
Worthy News reports from a biblical worldview with a commitment to accuracy, transparency, and editorial independence. Learn more about About Worthy News, our Editorial Standards, AI Use Policy, Ownership of Worthy News, News Tips and Corrections, and Worthy News Staff.
đź’ˇ Did you know? One of the best ways you can support Worthy News is by simply leaving a comment and sharing this article.
📢 Social media algorithms push content further when there’s more engagement — so every 👍 like, 💬 comment, and 🔄 share helps more people discover the truth. 🙌